• Robert R. Jacobson


Leprosy (Hansen’s disease) is a chronic infectious disease caused by Mycobacterium leprae that primarily affects the skin, peripheral nerves, eyes, and mucous membranes. It has been known for well over 2000 years and afflicts more than 10 million people worldwide, mostly in underdeveloped nations. Hanseno33) discovered the etiological agent over 100 years ago, but it has still not definitely been cultured in artificial media, and there is much about the disease process we do not yet understand. In particular, relatively few good studies on the epidemiology and control of leprosy have been done.


Household Contact Leprosy Patient Lepromatous Leprosy Mycobacterium Leprae Skin Scraping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abe, M., Specific serodiagnostic tests for leprosy, in: A Window on Leprosy (B. R. Chatterjee, ed.), pp. 235–241, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  2. 2.
    Abe, M., Fluorescent leprosy antibody absorption (Fla-Abs) test for detecting subclinical infection with Mycobacterium leprae, Int. J. Lepr. 47:379 (1979) (abstract).Google Scholar
  3. 3.
    Badger, L. F., Leprosy in the United States, Public Health Rep. 70:525–535 (1955).PubMedCrossRefGoogle Scholar
  4. 4.
    Badger, L. F., Epidemiology, in : Leprosy in Theory and Practice, 2nd ed. (R. G. Cochrane and T. F. Davey, eds.), pp. 69–97, John Wright, Bristol, 1964.Google Scholar
  5. 5.
    Bechelli, L. M., Garbojosa, P. G., Gyi, M. M., and Martinez-Dominguez, V., Site of early skin lesions in children with leprosy, Bull. WHO 48:107–111 (1973)PubMedGoogle Scholar
  6. 6.
    Bechelli, L. M., Lwin, K., Garbajosa, P. G., Gyi, M. M., Uemura, K., Sundaresan, T., Tamondong, C., Matejka, M., Sansarricq, H., and Walter, J., Bcg vaccination of children against leprosy: Nine-year findings of the controlled Who trial in Burma, Bull. WHO 51:93–99 (1974).PubMedGoogle Scholar
  7. 7.
    Bedi, B. M. S., Harris, E. B., Narayanan, E., and Kirchheimer, W. F., Delayed hypersensitivity tests with Mycobacterium leprae purified protein derivative, Lepr. India 48:8–18 (1976).PubMedGoogle Scholar
  8. 8.
    Brown, J. A. K., Stone, M. M., and Southerland, J., Trial of Bcg vacdnation against leprosy in Uganda, Lepr. Rev. 40:3–7 (1969).PubMedGoogle Scholar
  9. 9.
    Brubaker, M. L., Binford, C. H., and Trautman, J. R., Occurrence of leprosy in U.S. veterans after service in endemic areas abroad, Public Health Rep. 84:1051–1058 (1969).PubMedCrossRefGoogle Scholar
  10. 10.
    Brubaker, M. L., and Johnwick, E. B., Ten-year review of hospital admissions of patients with leprosy, Public Health Rep. 83:155–160 (1968).PubMedCrossRefGoogle Scholar
  11. 11.
    Bullock, W. E., Studies of immune mechanisms in leprosy. I. Depression of delayed allergic responses to skin test antigens, N. Engl. J. Med. 278:298–304 (1968).CrossRefGoogle Scholar
  12. 12.
    Bullock, W. E., Fields, J. P., and Brandriss, M. W., An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy, N. Engl. J. Med. 287:1053–1049 (1972).PubMedCrossRefGoogle Scholar
  13. 13.
    Chacko, C. J. G., Mohan, M., Jesudasan, K., Job, C. K., and Fritschi, E. P., Primary leprosy involvement of nasal mucosa in apparently healthy household contacts of leprosy patients, Int. J. Lepr. 47:417 (1979) (abstract).Google Scholar
  14. 14.
    Chakravatti, M. R., and Vogel, F., A twin study Orn leprosy, Topics in Human Genetics, No. 1, Georg Thiemes, Stuttgart, 1973.Google Scholar
  15. 15.
    Closs, O., In vitro lymphocyte response to purified protein derivative, Bcg and Mycobacterium leprae in a population not exposed to leprosy, Infect. Immun. 11:1163–1169 (1975).PubMedGoogle Scholar
  16. 16.
    Closs, O., Mshana, R. N., and Harboe, M., Antigenic analysis of Mycobacterium leprae, Int. J. Lepr. 47:374 (1979) (abstract).Google Scholar
  17. 17.
    Cochrane, R. G., The history of leprosy and its spread throughout the world, in: Leprosy in Theory and Practice, 2nd ed. (R. G. Cochrane and T. F. Davey, eds.), pp. 1–12, John Wright, Bristol, 1964.Google Scholar
  18. 18.
    Convit, J., Pinardi, M. E., Ochoa, G., Ulrich, M., Avila, J. L., and Goihman-Ahr, M., Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria, Clin. Exp. Immunol. 17:261–265 (1974).PubMedGoogle Scholar
  19. 19.
    Davey, T. F., and Rees, R. J. W., The nasal discharge in leprosy: Clinical and bacteriologic aspects, Lepr. Rev. 45:121–134 (1974).PubMedGoogle Scholar
  20. 20.
    Desikan, K. B., Viability of Mycobacterium leprae outside the human body, Lepr. Rev. 48:231–235 (1977).PubMedGoogle Scholar
  21. 21.
    Devries, R. R. P., Lai, R. F. M., Fat, A., Nijenhuis, L. E., and Vanrood, J. J., Hla-linked genetic control of host response to Mycobacterium leprae, Lancet 2:1328–1330 (1976).CrossRefGoogle Scholar
  22. 22.
    Dharmendra and Chatterjee, B. R., Prognostic value of the lepromin test in contacts of leprosy cases, Lepr. India 27:149–158 (1955).Google Scholar
  23. 23.
    Drutz, D. J., Chen, T. S. N., and Lu, W. H., The continuous bacteremia of lepromatous leprosy, N. Engl. J. Med. 287:159–164 (1972).PubMedCrossRefGoogle Scholar
  24. 24.
    Enna, C. D., Jacobson, R. R., Trautman, J. R., and Sturdivant, M., Leprosy in the United States, 1967–1976, Public Health Rep. 93:468–473 (1978).PubMedGoogle Scholar
  25. 25.
    Faget, G. P., Pogge, R. C., Johansen, F. A., Dinan, J. F., Prejean, B. M., and Eccles, C. G., The promin treatment of leprosy: A progress report, Public Health Rep. 58:1729–1741 (1943).CrossRefGoogle Scholar
  26. 26.
    Filice, G. A., and Fraser, D. W., Management of household contacts of leprosy patients, Ann. Intern. Med. 88:538–542 (1978).PubMedGoogle Scholar
  27. 27.
    Fisher, C. A., and Barksdale, L., Elimination of the acid-fastness but not the gram positivity of leprosy bacilli after extraction with pyridine, J. Bacteriol. 106:707–708 (1971).PubMedGoogle Scholar
  28. 28.
    Godal, T., Growing points in leprosy research. 3. Immunological detection of subclinical infection in leprosy, Lepr. Rev. 45:22–30 (1974).PubMedGoogle Scholar
  29. 29.
    Godal, T., Löfgren, M., and Negassi, K., Immune response to Mycobacterium leprae of healthy leprosy contacts, Int. J. Lepr. 40:243–250 (1972).Google Scholar
  30. 30.
    Godal, T., and Negassi, K., Subclinical infection in leprosy, Br. Med. J. 3:557–559 (1973).PubMedCrossRefGoogle Scholar
  31. 31.
    Gray, H. H., and Dreisbach, J. A., Leprosy among foreign missionaries in northern Nigeria, Int. J. Lepr. 29:279–290 (1961).PubMedGoogle Scholar
  32. 32.
    Guinto, R. S., Epidemiology of leprosy: Current views, concepts and problems, in: A Window on Leprosy (B. R. Chatterjee, ed.), pp. 36–53, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  33. 33.
    Hansen, G. H. A., Undersogelser angaende Spedalskhedens Arsager, Nor. Mag. Laegevidensk. 4:76–79 (1874).Google Scholar
  34. 34.
    Harboe, M., and Closs, O., A revival of interest in antibody studies in leprosy?, Int. J. Lepr. 47:372 (1979) (abstract).Google Scholar
  35. 35.
    Hastings, R. C., Transfer factor as a probe of the immune deficit in lepromatous leprosy, Int. J. Lepr. 45:281–291 (1977) .Google Scholar
  36. 36.
    Hastings, R. C., Morales, M. J., Shannon, E. J., and Jacobson, R. R., Preliminary results on the safety and efficacy of transfer factor in leprosy, in: Transfer Factor: Basic Properties and Clinical Application (M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick, eds.), pp. 465–476, Academic Press, New York, San Francisco, London, 1976.Google Scholar
  37. 37.
    Immunological problems in leprosy research (2), Bull. WHO 48:483–492 (1973).Google Scholar
  38. 38.
    Jacobson, R. R., The clinical aspects of dapsone resistance, in: A Window on Leprosy (B. R. Chatterjee, ed.), pp. 146–152, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  39. 39.
    Jacobson, R. R., and Hastings, R. C., Primary sulfone resistant leprosy, Int. J. Lepr. 46:116 (1978).Google Scholar
  40. 40.
    Jacobson, R. R., and Trautman, J. R., The treatment of leprosy with the sulfones. I. Faget’s original 22 patients: A 30-year follow-up on sulfone therapy for leprosy, Int. J. Lepr. 39:725–736 (1971).Google Scholar
  41. 41.
    Job, C. K., Chacko, C. J. G., Taylor, P. M., Daniel, M., and Jesudian, G., Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test, Int. J. Lepr. 44:256–266 (1976).Google Scholar
  42. 42.
    Kirchheimer, W. F., and Prabhakaran, K., Metabolic and biologic tests on mycobacteria once labeled as leprosy bacilli, Int. J. Lepr. 36:589 (1968).Google Scholar
  43. 43.
    Kirchheimer, W. F., Sanchez, R. M., and Shannon, E. J., Effect of specific vaccine on cell-mediated immunity of armadillos against Mycobacterium leprae, Int. J. Lepr. 46:353–357 (1978).Google Scholar
  44. 44.
    Kirchheimer, W. F., and Storrs, E. E., Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo, Int. J. Lepr. 39:693–702 (1971).Google Scholar
  45. 45.
    Kluth, F. C., Leprosy in Texas: Risk of contracting the disease in the household, Tex. State J. Med. 52:758–789 (1956) .Google Scholar
  46. 46.
    Krieg, R. E., and Meyers, W. M., Demonstration of Mycobacterium leprae in tissues from bacteriologically negative treated lepromatous leprosy patients, Int. J. Lepr. 47:367 (1979) (abstract).Google Scholar
  47. 47.
    Kronvall, G., Closs, O., and Bjune, G., Common antigen of Mycobacterium leprae, M. leprameurium, M. avium and M. fortitutum in comparative studies using two different types of antisera, Infect. Immun. 16:542–546 (1977).PubMedGoogle Scholar
  48. 48.
    Lechat, M. F., Bellut, C., and Mission, C. B., The use and limitations of epidemiometric models in leprosy, in: A Window on Leprosy (B. R. Chatterjee, ed.), pp. 64–70, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  49. 49.
    Lieker, D. L., Epidemiological and immunological surveys in Netherlands New Guinea, Lepr. Rev. 31:241–259 (1960).Google Scholar
  50. 50.
    Leprosy, Weekly Epidemiol. Rec. 54:17–23 (1979).Google Scholar
  51. 51.
    Leprosy-like disease in wild-caught armadillos, Morbid. Mortal. Weekly Rep. 25:18, 23 (1976).Google Scholar
  52. 52.
    Leprosy Surveillance Report, No. 3, Centers for Disease Control, Hew Publ. No. (Cdc) 76–8095 (issued April 1976) .Google Scholar
  53. 53.
    Lim, S. E., Kszkiss, E. F., Jacobson, R. R., Choi, Y. S., and Good, R. A., Thymus-dependent lymphocytes of peripheral blood in leprosy patients, Infect. Immun. 9:394–399 (1974).PubMedGoogle Scholar
  54. 54.
    Mathai, R., Rao, P. S. S., and Job, C. K., Risks of treating leprosy in a general hospital, Int. J. Lepr. 47:322 (1979) (abstract).Google Scholar
  55. 55.
    Nenzel, S., Bjune, G., Kronvall, G., and Morrow, R. H., Lymphocyte transformation test in healthy leprosy contacts: Influence of household exposure, Int. J. Lepr. 47:374 (1979) (abstract).Google Scholar
  56. 56.
    Meyers, W. M., Kvernes, S., and Binford, C. H., Comparison of reactions to human and armadillo lepromins in leprosy, Int. J. Lepr. 43:218–225 (1975).Google Scholar
  57. 57.
    Mohamed Ali, P., and Ramanujam, K., Leprosy in twins, Int. J. Lepr. 34:405–407 (1966).Google Scholar
  58. 58.
    Narayanan, E., Sreevatsa, Kirchheimer, W. F., and Bedi, B. M. S., Transfer of leprosy bacilli from patients to mouse footpads by Aedes aegypti, Lepr. India 49:181–186 (1977).PubMedGoogle Scholar
  59. 59.
    Newell, K. W., An epidemiologist’s view of leprosy, Bull. WHO 34:827–857 (1966).PubMedGoogle Scholar
  60. 60.
    Noordeen, S. K., Longterm effects of chemoprophylaxis among contacts of lepromatous cases, Lepr. India 49:504–509 (1977).PubMedGoogle Scholar
  61. 61.
    Noussitou, F. M., Sansarricq, H., and Walter, J., Leprosy in Children, World Health Organization, Geneva, 1976.Google Scholar
  62. 62.
    Oleinick, A., Altered immunity and cancer risks: A review of the problem and analysis of the cancer mortality experience of leprosy patients, J. Natl. Cancer Inst. 43:775–781 (1969).PubMedGoogle Scholar
  63. 63.
    Pattyn, S. R., Comportement de diverses espéces de mycobactèries dans la patte de souris, Ann. Inst. Pasteur 109:309–313 (1965).Google Scholar
  64. 64.
    Pattyn, S. R., Use of the mouse footpad in studying thermoresistance of Mycobacterium leprae, Int. J. Lepr. 33:611–615 (1965).PubMedGoogle Scholar
  65. 65.
    Pearson, J. M. H., Haile, G. S., and Rees, R. J. W., Primary dapsone-resistant leprosy, Lepr. Rev. 48:129–132 (1977).PubMedGoogle Scholar
  66. 66.
    Pedley, J. C., The hypothesis of skin to skin transmission, Lepr. Rev. 48:295–297 (1977).PubMedGoogle Scholar
  67. 67.
    Peters, J. H., Gordon, G. R., and Colwell, W. T., The fluorometric measurement of 4,4’-diaminodiphenyl sulfone and its acetylated derivative in plasma and urine, J. Lab. Clin. Med. 76:338–348 (1970).PubMedGoogle Scholar
  68. 68.
    Prabhakaran, K., Harris, E. B., and Kirchheimer, W. F., Survival of Mycobacterium leprae in tissues kept frozen at — 80°C., Microbios Lett. 1:193–195 (1976).Google Scholar
  69. 69.
    Prabhakaran, K., and Kirchheimer, W. F., Use of 3,4-dihydroxyphenylalanine oxidation in the identification of Mycobacterium leprae, J. Bacteriol. 92:1267–1268 (1966).PubMedGoogle Scholar
  70. 70.
    Quagliato, R., Bechelli, L. M., and Marques, R. M., Bacterial negativity and reactivation (relapse) in lepromatous outpatients under sulfone treatment, Int. J. Lepr. 38:250–263 (1970).Google Scholar
  71. 71.
    Rasi, E., Castellazzi, Z., Garcia, L., Quevedo, L., and Convit, J., Evaluation of “chemical isolation” in 1,168 leprosy patients’ homes, Int. J. Lepr. 43:101–105 (1975).Google Scholar
  72. 72.
    Rea, T. H., Current concepts in the immunology of leprosy, Arch. Dermatol. 113:345–352 (1977).PubMedCrossRefGoogle Scholar
  73. 73.
    Rees, R. J. W., and Mcdougall, A. C., Airborne infection with Mycobacterium leprae in mice, J. Med. Microbiol. 10:63–68 (1977).PubMedCrossRefGoogle Scholar
  74. 74.
    Rees, R. J. W. and Meade, T. W., Comparison of modes of spread and incidence of tuberculosis and leprosy, Lancet 1:47–49 (1974).PubMedCrossRefGoogle Scholar
  75. 75.
    Report of the Workshop on Microbiology of the Xi International Leprosy Congress, lnt. J. Lepr. 47:291–294 (1979).Google Scholar
  76. 76.
    Ridley, D. S., Reactions in leprosy, Lepr. Rev. 40:77–81 (1969).PubMedGoogle Scholar
  77. 77.
    Ridley, D. S., and Jopling, W. H., A classification of leprosy for research purposes, Lepr. Rev. 33:119–128 (1962).PubMedGoogle Scholar
  78. 78.
    Rotberg, A., Bechelli, L. M., and Keil, H., The Mitsuda reaction in a non-leprous area, Int. J. Lepr. 18:209–220 (1950).Google Scholar
  79. 79.
    Russell, D. A., Worth, R. M., Scott, G. C., Vincin, D. R., Jano, B., Fasal, P., and Shepard, C. C., Experience with acedapsone (Dadds) in a therapeutic trial in New Guinea and the chemoprophylactic trial in Micronesia, Int. J. Lepr. 44:170–176 (1976).Google Scholar
  80. 80.
    Sanchez, R. M., and Kirchheimer, W. F., Examirnation of North American armadillos for mycobacteriosis, Int. J. Lepr. 47:361 (1979) (abstract).Google Scholar
  81. 81.
    Sansarricq, H., Walter, J., and Seal, K. S., The World Health Organization in leprosy control, in: A Window on Leprosy (B. R. Chatterjee, ed.), pp. 12–22, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  82. 82.
    Sehgal, V. M., Rege, V. L., and Singh, K. P., The age of onset of leprosy, Int. J. Lepr. 45:52–55 (1977).Google Scholar
  83. 83.
    Shepard, C. C., The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J. Exp. Med. 112:445–454 (1960).PubMedCrossRefGoogle Scholar
  84. 84.
    Shepard, C. C., Stability of Mycobacterium leprae and temperature optimum for growth, Int. J. Lepr. 33:541–547 (1965).PubMedGoogle Scholar
  85. 85.
    Shepard, C. C., Experimental chemotherapy in leprosy, then and now, Int. J. Lepr. 41:307–319 (1973).Google Scholar
  86. 86.
    Shepard, C. C., and Mcrae, D. H., Mycobacterium leprae in mice: Minimal infectious dose, relationship between staining quality and infectivity, and effect of cortisone, J. B acteriol. 89:365–372 (1965).Google Scholar
  87. 87.
    Shepard, C. C., and Saitz, E. W., Lepromin and tuberculin reactivity in adults not exposed to leprosy, J. Immunol. 99:637–642 (1967).PubMedGoogle Scholar
  88. 88.
    Shepard, C. C., Walker, L. L., and Vanlandingham, R., Heat stability of Mycobacterium leprae immunogenicity, Infect. Immun. 22:87–93 (1978).PubMedGoogle Scholar
  89. 89.
    Shield, M. J., Stanford, J. L., and Rook, G. A. W., The reason for the reduction of the protective efficacy of Bcg in Burma, Int. J. Lepr. 47:319–320 (1979) (abstract).Google Scholar
  90. 90.
    Skinsnes, O. K., Matsuo, E., Chang, P. H. C., and Ersson, B., Cultivation of Mycobacterium leprae in hyaluronic acid based medium. 1. Preliminary report. Int. J. Lepr. 43:193–203 (1975).Google Scholar
  91. 91.
    Stoner, G. L., Touw, J., Belehu, A., and Naafs, B., In-vitro lymphoproliferative responses to Mycobacterium leprae of Hla-D-identical siblings of lepromatous leprosy patients, Lancet 2:543–547 (1978).PubMedCrossRefGoogle Scholar
  92. 92.
    Touw-Langendijk, E. M. J., and Naafs, B., Relapses in leprosy after release from control, Lepr. Rev. 50:123–127 (1979).PubMedGoogle Scholar
  93. 93.
    Wade, H. W., and Ledowsky, V., The leprosy epidemic at Nauru: A review with data on status since 1937, Int. J. Lepr. 20:1–29 (1952).PubMedGoogle Scholar
  94. 94.
    Waldorf, D. S., Sheagren, J. N., Trautman, J. R., and Block, J. B., Impaired delayed hypersensitivity in patients with lepromatous leprosy, Lancet 2:773–776 (1966).PubMedCrossRefGoogle Scholar
  95. 95.
    Walsh, G. P., Storrs, E. E., Burchfield, H. P., Cottrell, E. H., Vidrine, M. F.,and Binford, C. H., Leprosy-like disease occurring naturally in armadillos, J. Reticuloendothel. Soc. 18:347–351 (1975).PubMedGoogle Scholar
  96. 96.
    Wardekar, R. V., Chemoprophylaxis in leprosy, Lepr. India 41:240–246 (1969).Google Scholar
  97. 97.
    Waters, M. F. R., Significance of the lepromin test in tuberculin-negative volunteers permanently resident in a leprosy-free area, Int. J. Lepr. 41:563 (1973).Google Scholar
  98. 98.
    Waters, M. F. R., Rees, R. J. W., Mcdougall, A. C., and Weddell, A. G. M., Ten years of dapsone in lepromatous leprosy: Clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli, Lepr. Rev. 45:288–298 (1974).PubMedGoogle Scholar
  99. 99.
    Wheeler, E. A., Practical notes on technique for use in preparing sections from biopsies of the skin of histopathological examinations, in: Leprosy in Theory and Practice, 2nd ed. (R. G. Cochrane and T. F. Davey, eds.), pp. 626–631, John Wright, Bristol, 1964.Google Scholar
  100. 100.
    The Who Expert Committee on Leprosy, Fourth Report, W.H.O. Tech. Rep. Ser., No. 459, World Health Organization, Geneva, 1970.Google Scholar
  101. 101.
    The Who Expert Committee on Leprosy, Fifth Report, W.H.O. Tech. Rep. Ser., No. 607, World Health Organization, Geneva, 1977.Google Scholar

Suggested Reading

  1. 102.
    Worth, R. M., and Wong, K. O., Further notes on the incidence of leprosy in Hong Kong children living with a lepromatous parent, Int. J. Lepr. 38:745–749 (1971).Google Scholar
  2. World Health Organization, A Guide to Leprosy Control, Publ. No. Isbn 92 4 154147 4, Geneva, 1980.Google Scholar
  3. Binford, C. H., and Meyers, W. M., Leprosy in: Pathology of Tropical and Extraordinary Diseases, Vol. 1 (C. H. Binford and D. H. Connor, eds.), pp. 205–225, Armed Forces Institute of Pathology, Washington, D.C., 1976.Google Scholar
  4. Bullock, W. E., Leprosy: A model of immunological perturbation in chronic infection, J. Infect. Dis. 137:341–354 (1978).PubMedCrossRefGoogle Scholar
  5. Chatterjee, B. R. (ed.), A Window on Leprosy, Statesman Commercial Press, Calcutta, 1978.Google Scholar
  6. Symposium on leprosy, South. Med. J. 69:969–996 (1976).CrossRefGoogle Scholar
  7. The Who Expert Committee on Leprosy, Fifth Report, W.H.O. Tech. Rep. Ser., No. 607, World Health Organization, Geneva, 1977.Google Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Robert R. Jacobson
    • 1
  1. 1.Clinical BranchU.S. Public Health Service HospitalCarvilleUSA

Personalised recommendations